Literature DB >> 26813215

Safety of Propranolol Therapy for Severe Infantile Hemangioma.

Sorilla Prey1, Jean-Jacques Voisard2, Alain Delarue2, Geneviève Lebbe2, Alain Taïeb1, Christine Leaute-Labreze1, Khaled Ezzedine1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26813215     DOI： 10.1001/jama.2015.13969

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Evaluation of the efficacy and safety of topical timolol maleate combined with oral propranolol treatment for parotid mixed infantile hemangiomas.

Authors:  Shuang Tong; Da-Peng Xu; Zi-Mei Liu; Yang Du; Xu-Kai Wang
Journal:  Oncol Lett       Date:  2016-07-07       Impact factor: 2.967

2.  Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study.

Authors:  Yi Ji; Siyuan Chen; Bo Xiang; Yang Yang; Liqing Qiu
Journal:  Sci Rep       Date:  2017-05-04       Impact factor: 4.379

3.  Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.

Authors:  Maya El Hachem; Francesco Gesualdo; Andrea Diociaiuti; Irene Berti; Nadia Vercellino; Valeria Boccaletti; Iria Neri; Giulio Porcedda; Antonella Greco; Claudia Carnevale; Teresa Oranges; Mario Cutrone; Pietro Dalmonte
Journal:  Ital J Pediatr       Date:  2017-04-19       Impact factor: 2.638

4.  Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management.

Authors:  Yi Ji; Siyuan Chen; Qi Wang; Bo Xiang; Zhicheng Xu; Lin Zhong; Kaiying Yang; Guoyan Lu; Liqin Qiu
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

5.  Quality of life in children with infantile hemangioma: a case control study.

Authors:  Chuan Wang; Yanan Li; Bo Xiang; Fei Xiong; Kai Li; Kaiying Yang; Siyuan Chen; Yi Ji
Journal:  Health Qual Life Outcomes       Date:  2017-11-16       Impact factor: 3.186

Review 6.  Cardiac arrest in a toddler treated with propranolol for infantile Hemangioma: a case report.

Authors:  Alvise Tosoni; Mario Cutrone; Maurizio Dalle Carbonare; Andrea Pettenazzo; Giorgio Perilongo; Stefano Sartori
Journal:  Ital J Pediatr       Date:  2017-11-17       Impact factor: 2.638

7.  Deep coma in a child treated with propranolol for infantile hemangioma.

Authors:  Ilirjana Bakalli; Elmira Kola; Robert Lluka; Ermela Celaj; Durim Sala; Inva Gjeta; Sashenka Sallabanda; Dea Klironomi
Journal:  BMC Pediatr       Date:  2019-07-02       Impact factor: 2.125

8.  Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies.

Authors:  Li Li; Bin Yang; Li Wei; Bin Zhang; Xiao-Feng Han; Zi-Gang Xu; Lin Ma
Journal:  BMC Pediatr       Date:  2020-02-19       Impact factor: 2.125

9.  Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial.

Authors:  Silvia Lanfranconi; Elisa Scola; Giulio Andrea Bertani; Barbara Zarino; Roberto Pallini; Giorgio d'Alessandris; Emanuela Mazzon; Silvia Marino; Maria Rita Carriero; Emma Scelzo; Giuseppe Faragò; Marco Castori; Carmela Fusco; Antonio Petracca; Leonardo d'Agruma; Laura Tassi; Piergiorgio d'Orio; Maria Grazia Lampugnani; Enrico Bjorn Nicolis; Antonella Vasamì; Deborah Novelli; Valter Torri; Jennifer Marie Theresia Anna Meessen; Rustam Al-Shahi Salman; Elisabetta Dejana; Roberto Latini
Journal:  Trials       Date:  2020-05-12       Impact factor: 2.279

10.  Propranolol Treatment for Infantile Hemangiomas: Short-Term Adverse Effects and Follow-Up to Age Two.

Authors:  Xueqing Li; Kun Yang; Hongwen Li; Ran Huo
Journal:  Biomed Res Int       Date:  2019-11-25       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.